Search results
Walgreens to take a hard look at underperforming stores, could shutter hundreds more
Associated Press via Yahoo News· 2 weeks agoWalgreens is finalizing a plan to fix its U.S. business that could result in closing hundreds of...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance· 2 months agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance· 2 months agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
Why big Medicare Advantage insurers may root for Biden to lose in 2024
Yahoo Finance· 3 months agoInsurance giants have a bigger stake in this year’s presidential election after recent moves by the...
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
Zacks via Yahoo News· 3 months agoThough early-stage results on Vincerx's (VINC) experimental drug did show signs of anti-tumor...
Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
Yahoo Finance· 3 months agoViking Therapeutics (VKTX) reported positive early phase results for its oral weight-loss drug...
Medicare Advantage chaos is making life more difficult for hospitals, insurers — and seniors
Yahoo Finance· 4 months agoHospitals and insurance giants are clashing over Medicare Advantage plans as both sides try to...
Experimental weight loss drug from a small biotech could out-do Ozempic
Washington Post via Yahoo News· 4 months agoViking Therapeutics posted results of an experimental drug that showed even better weight loss than...
UnitedHealth shares tumble after health care giant reports soaring medical costs in 4Q
Associated Press via Yahoo News· 6 months agoUnitedHealth Group turned in a better-than-expected fourth quarter but surprised Wall Street with...